Stocks and Investing Stocks and Investing
Thu, April 27, 2023

Patrick Trucchio Reiterated (ALNY) at Strong Buy and Held Target at $415 on, Apr 27th, 2023


Published on 2024-10-28 03:05:32 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $415 on, Apr 27th, 2023.

Patrick has made no other calls on ALNY in the last 4 months.



There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 4 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Hoang of "SMBC Nikko" Initiated at Hold and Held Target at $220 on, Wednesday, April 26th, 2023
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $210 on, Tuesday, April 4th, 2023
  • Jessica Fung of "JP Morgan" Maintained at Hold with Decreased Target to $196 on, Friday, March 3rd, 2023
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $143 on, Monday, January 23rd, 2023


These are the ratings of the 6 analyists that currently disagree with Patrick


  • William Pickering of "Bernstein" Initiated at Buy and Held Target at $243 on, Tuesday, March 21st, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Friday, February 24th, 2023
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $249 on, Friday, February 24th, 2023
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $291 on, Friday, February 24th, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $265 on, Friday, February 24th, 2023
  • Michael King of "EF Hutton" Reiterated at Strong Buy and Held Target at $304 on, Friday, February 24th, 2023
Contributing Sources